{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:28:01Z","timestamp":1792787281429,"version":"4.5.0"},"reference-count":10,"publisher":"BMJ","issue":"1","funder":[{"name":"Italian Drug Agency"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2022,3,29]]},"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1136\/ejhpharm-2021-003053","type":"journal-article","created":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T13:25:54Z","timestamp":1649683554000},"page":"46-49","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["A pharmacovigilance study on antiepileptic medications in a paediatric hospital in Italy"],"prefix":"10.1136","volume":"31","author":[{"given":"Nicoletta","family":"Monti Guarnieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Pompilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Marini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Battista","family":"Ortenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Andresciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Maria Felicita","family":"Garzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Consuelo","family":"Ieracitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6946-8638","authenticated-orcid":false,"given":"Carlo","family":"Polidori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,4,11]]},"reference":[{"key":"2024102217151943000_31.1.46.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68182-8"},{"key":"2024102217151943000_31.1.46.2","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12550"},{"key":"2024102217151943000_31.1.46.3","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13709"},{"key":"2024102217151943000_31.1.46.4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00228-016-2168-0","article-title":"Antiepileptic drug use in Italian children over a decade","volume":"73","author":"Putignano","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"key":"2024102217151943000_31.1.46.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.107966"},{"key":"2024102217151943000_31.1.46.6","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30312-6"},{"key":"2024102217151943000_31.1.46.7","doi-asserted-by":"crossref","first-page":"107989","DOI":"10.1016\/j.yebeh.2021.107989","article-title":"Pediatric adverse reactions to antiseizure medications - an analysis of data from the Italian spontaneous reporting system (2001-2019)","volume":"119","author":"Franco","year":"2021","journal-title":"Epilepsy Behav"},{"key":"2024102217151943000_31.1.46.8","unstructured":"Italian Drug Agency . Adverse drug reaction recording form. Available: https:\/\/www.aifa.gov.it\/moduli-segnalazione-reazioni-avverse"},{"key":"2024102217151943000_31.1.46.9","unstructured":"Medical Dictionary for Regulatory Activities. Available: https:\/\/www.meddra.org\/how-to-use\/basics\/hierarchy"},{"key":"2024102217151943000_31.1.46.10","article-title":"Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data","volume":"12","author":"Nevitt","year":"2017","journal-title":"Cochrane Database Syst Rev"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2021-003053","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T20:16:30Z","timestamp":1729628190000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2021-003053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,11]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12,27]]},"published-print":{"date-parts":[[2024,1]]}},"alternative-id":["10.1136\/ejhpharm-2021-003053"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2021-003053","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"value":"2047-9956","type":"print"},{"value":"2047-9964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,11]]}}}